Fierce Medical Affairs Strategic Summit 2024

Gail Cawkwell, MD, PhD has served as Aclaris’ Chief Medical Officer since June 2022. Dr. Cawkwell, a pediatric rheumatologist and epidemiologist, has over 23 years of pharmaceutical clinical development and medical affairs experience, including fifteen years as an enterprise and... Read More →

Dr. Rangwala brings more than a decade of experience in oncology and drug development to her role at Karyopharm. She was most recently the Chief Medical Officer at Aravive, where she led the clinical development of batiraxcept across multiple tumor types. Prior to Aravive, she served... Read More →

Kirk Shepard, M.D., is a U.S. board-certified medical oncologist and hematologist with more than 30 years of experience in the pharmaceutical industry. Prior to PDS Biotechnology, he was Chief Medical Officer, Senior Vice President and Head of Global Medical Affairs Oncology at Eisai... Read More →

Dr. Stuart Hart is the corporate vice president and chief medical officer. He is responsible for Integra’s worldwide clinical development activities, including clinical research, clinical trial operations and medical affairs. Dr. Hart is also responsible for scientific and medical... Read More →